1. "Biomed Central Ltd"
  2. "Melanoma and Immunotherapeutics Service"
Formats
  1. Meeting Abstract (96)
  2. Journal Article (39)
  3. Editorial (3)
  4. Guidelines (3)
  5. Review (2)
  6. Miscellaneous (1)
Groups
  1. Department of Medicine (144)
  2. Melanoma and Immunotherapeutics Service (144)
  3. Solid Tumor Oncology Division (144)
  4. GSK Faculty (85)
  5. Melanoma Disease Management Team (67)
  6. Sloan Kettering Institute Postdocs (51)

More Groups

People
  1. Jedd Wolchok (83)
  2. Taha Merghoub (55)
  3. Michael Postow (42)
  4. Roberta Zappasodi (21)
  5. Sadna Budhu (21)
  6. Alexander Shoushtari (19)

More People

Years
  1. 2024 (2)
  2. 2023 (3)
  3. 2022 (22)
  4. 2021 (19)
  5. 2020 (21)
  6. 2019 (6)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (127)
  2. Journal of Translational Medicine (17)
Publishers
  1. Biomed Central Ltd (144)

Results (144)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Defining D-irAEs: Consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy
    Journal Article

    Chen, S. T.; Semenov, Y. R.; Alloo, A.; Bach, D. Q.; Betof Warner, A.; Bougrine, A.; Burton, L.; Cappelli, L. C.; Castells, M.; Cohen, J.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032)
    Journal Article

    Callahan, M.; Amin, A.; Kaye, F. J.; Morse, M. A.; Taylor, M. H.; Peltola, K. J.; Sharma, P.; O'Reilly, E. M.; Meadows Shropshire, S.; O'Brien, S.; more...
    Journal for ImmunoTherapy of Cancer (2024)

    Fulltext@MSK | Save
  • Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis
    Journal Article

    Badran, Y. R.; Zou, F.; Durbin, S. M.; Dutra, B. E.; Abu-Sbeih, H.; Thomas, A. S.; Altan, M.; Thompson, J. A.; Qiao, W.; Leet, D. E.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Management of immune-related cutaneous adverse events with dupilumab
    Journal Article

    Kuo, A. M. S.; Gu, S.; Stoll, J.; Moy, A. P.; Dusza, S. W.; Gordon, A.; Haliasos, E. C.; Janjigian, Y.; Kraehenbuehl, L.; Quigley, E. A.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: A phase 1 study
    Journal Article

    Hamid, O.; Hassel, J. C.; Shoushtari, A. N.; Meier, F.; Bauer, T. M.; Salama, A. K. S.; Kirkwood, J. M.; Ascierto, P. A.; Lorigan, P. C.; Mauch, C.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Assessing the correlation between CD8 cell PET imaging with 89-ZR-crefmirlimab berdoxam and CD8 cell immunohistochemistry in patients with advanced cancer receiving immunotherapy
    Meeting Abstract

    Postow, M.; Mauguen, A.; Farwell, M.; Gordon, M.; Hays, D.; Wong, J.; Pal, S.; Chen, D.; Ulaner, G.; McConathy, J.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Uncovering the hidden structure of T cell compositions in peripheral blood after immune checkpoint inhibitor
    Meeting Abstract

    Peng, X.; Lee, J.; Adamow, M.; Maher, C.; Callahan, M.; Panageas, K.; Shen, R.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Signal-regulatory protein alpha (SIRPĪ±) confers tumor cell resistance to anti-tumor immunity
    Meeting Abstract

    Weng, C. H.; Hamadene, L.; Eghbali, S.; Venkatesh, D.; Monette, S.; Mangarin, L.; Samaan, F.; Liu, C.; Holland, P.; Wolchok, J.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Comparative safety and effectiveness of IL6R inhibitors, TNF inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis
    Meeting Abstract

    Bass, A.; Abdel-Wahab, N.; Sparks, J.; Reid, P.; Calabrese, C.; Jannat-Khah, D.; Rajesh, D.; Ghosh, N.; Mushtak, K.; Al Haj, F.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Immune checkpoint blockade enhances cyclophosphamide induced anti-tumor immunity in a preclinical melanoma model
    Meeting Abstract

    George, M.; Betof, A.; Merghoub, T.; Hamadene, L.; Hirschhorn, D.; Houghton, A.; Wolchok, J.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save